Flexotron Cross 60mg/3ml, syringe

The medical device is indicated for the treatment of joint pain in osteoarthritis (OA).

Indications

The medical device is indicated for the treatment of joint pain due to osteoarthritis (OA).

Composition

Viscoelastic sterile implant for intra-articular injections Flexotron ® Cross, based on
cross-linked sodium hyaluronate, 60 mg/3.0 ml, in glass syringes.

Contraindications

Do not use the implant to treat patients with hypersensitivity to hyaluronate-based products.

Intra-articular injections are contraindicated in cases of past or current infections or skin diseases in the immediate vicinity of the injection site.

Side Effects

The main side effects of using an implant are pain, swelling and stiffness in the joint where the injection was made.

Storage conditions

Store in accordance with the information on the packaging. Permissible temperature limits are from 2 to 30 degrees. Do not expose to sunlight, do not freeze.

Shelf life

3 years

Manufacturer

CyVision Biotech Inc., Taiwan